| P2093 | author name string | Lin Wang | |
| | Haitao Yang | |
| | Lisa C. Rohan | |
| P2860 | cites work | Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity | Q21133918 |
| | First phase 1 double-blind, placebo-controlled, randomized rectal microbicide trial using UC781 gel with a novel index of ex vivo efficacy | Q21135264 |
| | Antiretroviral pre-exposure prophylaxis prevents vaginal transmission of HIV-1 in humanized BLT mice | Q21144657 |
| | Quantification of the spatial distribution of rectally applied surrogates for microbicide and semen in colon with SPECT and magnetic resonance imaging | Q36468151 |
| | Acceptability of potential rectal microbicide delivery systems for HIV prevention: a randomized crossover trial | Q36674543 |
| | Current concepts in AIDS pathogenesis: insights from the SIV/macaque model | Q36705227 |
| | Drug concentrations after topical and oral antiretroviral pre-exposure prophylaxis: implications for HIV prevention in women | Q36839544 |
| | Quantitative assessment of altered rectal mucosal permeability due to rectally applied nonoxynol-9, biopsy, and simulated intercourse | Q36957266 |
| | A modified zinc acetate gel, a potential nonantiretroviral microbicide, is safe and effective against simian-human immunodeficiency virus and herpes simplex virus 2 infection in vivo | Q37036620 |
| | A social ecology of rectal microbicide acceptability among young men who have sex with men and transgender women in Thailand | Q37066942 |
| | Lack of prophylactic efficacy of oral maraviroc in macaques despite high drug concentrations in rectal tissues | Q37123335 |
| | Preference for gel over suppository as delivery vehicle for a rectal microbicide: results of a randomised, crossover acceptability trial among men who have sex with men. | Q37159238 |
| | Vaginal and rectal topical microbicide development: safety and efficacy of 1.0% Savvy (C31G) in the pigtailed macaque | Q37862430 |
| | Safety and efficacy evaluations for vaginal and rectal use of BufferGel in the macaque model | Q37867259 |
| | Human lymphohematopoietic reconstitution and immune function in immunodeficient mice receiving cotransplantation of human thymic tissue and CD34(+) cells | Q37981545 |
| | HIV infections attributed to male-to-male sexual contact - metropolitan statistical areas, United States and Puerto Rico, 2010. | Q43519462 |
| | Rectal applications of nonoxynol-9 cause tissue disruption in a monkey model | Q44172316 |
| | Rectal douching among Peruvian men who have sex with men, and acceptability of a douche-formulated rectal microbicide to prevent HIV infection | Q45185929 |
| | Nonoxynol-9 enhances rectal infection by herpes simplex virus in mice | Q45754674 |
| | Prevalence of anal sex among heterosexuals in California and its relationship to other AIDS risk behaviors. | Q45978785 |
| | A human colorectal explant culture to evaluate topical microbicides for the prevention of HIV infection | Q46736849 |
| | Efficacy of Carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial | Q46871110 |
| | College students' reasons for nonuse of condoms within dating relationships | Q47326271 |
| | Mucosal HIV infection | Q47730254 |
| | Safety and toxicity of nonoxynol-9 gel as a rectal microbicide. | Q52536992 |
| | Quantitative imaging and sigmoidoscopy to assess distribution of rectal microbicide surrogates. | Q53481122 |
| | High-risk behaviors among men who have sex with men in 6 US cities: baseline data from the EXPLORE Study | Q56897894 |
| | Ex vivo culture of human colorectal tissue for the evaluation of candidate microbicides | Q61312701 |
| | Sexual behavior and selected health measures: men and women 15-44 years of age, United States, 2002 | Q64131535 |
| | Acceptability of a bioadhesive nonoxynol-9 gel delivered by an applicator as a rectal microbicide | Q73179863 |
| | Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques | Q73814670 |
| | Hyperosmolar sexual lubricant causes epithelial damage in the distal colon: potential implication for HIV transmission | Q79687951 |
| | Colorectal microbicide design: triple combinations of reverse transcriptase inhibitors are optimal against HIV-1 in tissue explants | Q84656743 |
| | Acceptability of oral versus rectal HIV preexposure prophylaxis among men who have sex with men and transgender women in Peru | Q86167001 |
| | Rectal microbicide development | Q87405838 |
| | Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men | Q24612082 |
| | Transcriptional profiling in pathogenic and non-pathogenic SIV infections reveals significant distinctions in kinetics and tissue compartmentalization | Q27318045 |
| | Heterosexual risk of HIV-1 infection per sexual act: systematic review and meta-analysis of observational studies | Q28307869 |
| | Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel | Q28473376 |
| | Rectal transmission of transmitted/founder HIV-1 is efficiently prevented by topical 1% tenofovir in BLT humanized mice | Q28488527 |
| | The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys | Q29547689 |
| | Anal sex among HIV-seronegative women at high risk of HIV exposure. The HIVNET Vaccine Preparedness Study 2 Protocol Team | Q30233648 |
| | Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection | Q30411459 |
| | An algorithm for the preclinical development of anti-HIV topical microbicides | Q30412043 |
| | Acceptability of UC781 gel as a rectal microbicide among HIV-uninfected women and men. | Q33833859 |
| | Sexual behavior, sexual attraction, and sexual identity in the United States: data from the 2006-2008 National Survey of Family Growth | Q33895589 |
| | Animal model for the therapy of acquired immunodeficiency syndrome with reverse transcriptase inhibitors | Q33957283 |
| | Identification of personal lubricants that can cause rectal epithelial cell damage and enhance HIV type 1 replication in vitro | Q34025707 |
| | Isolation of T-cell tropic HTLV-III-like retrovirus from macaques | Q34049156 |
| | Heterosexual anal sexuality and anal sex behaviors: a review | Q34107809 |
| | PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial | Q34138687 |
| | Genomic Analysis Reveals Pre- and Postchallenge Differences in a Rhesus Macaque AIDS Vaccine Trial: Insights into Mechanisms of Vaccine Efficacy | Q34485178 |
| | Rectal microbicide development. | Q34575590 |
| | Preclinical safety and efficacy assessments of dendrimer-based (SPL7013) microbicide gel formulations in a nonhuman primate model | Q34648571 |
| | A phase 1 randomized, double blind, placebo controlled rectal safety and acceptability study of tenofovir 1% gel (MTN-007). | Q34661892 |
| | Rectal microbicides: clinically relevant approach to the design of rectal specific placebo formulations | Q34704317 |
| | The nonnucleoside reverse transcriptase inhibitor MIV-150 in carrageenan gel prevents rectal transmission of simian/human immunodeficiency virus infection in macaques | Q34982693 |
| | A summary of preclinical topical microbicide rectal safety and efficacy evaluations in a pigtailed macaque model | Q34989166 |
| | The slippery slope: lubricant use and rectal sexually transmitted infections: a newly identified risk | Q35629984 |
| | Generation of HIV latency in humanized BLT mice | Q35666126 |
| | Preclinical evaluation of the HIV-1 fusion inhibitor L'644 as a potential candidate microbicide | Q35941336 |
| | Macaque studies of vaccine and microbicide combinations for preventing HIV-1 sexual transmission | Q36001347 |
| | Reformulated tenofovir gel for use as a dual compartment microbicide. | Q36159765 |
| | Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention | Q36171647 |
| | Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy | Q36315555 |
| | RMP-02/MTN-006: A phase 1 rectal safety, acceptability, pharmacokinetic, and pharmacodynamic study of tenofovir 1% gel compared with oral tenofovir disoproxil fumarate | Q36359092 |
| | A single dose of a MIV-150/Zinc acetate gel provides 24 h of protection against vaginal simian human immunodeficiency virus reverse transcriptase infection, with more limited protection rectally 8-24 h after gel use. | Q36359120 |
| | Safety and efficacy of tenofovir/IQP-0528 combination gels - a dual compartment microbicide for HIV-1 prevention | Q36409617 |
| | Compartmentalization of the gut viral reservoir in HIV-1 infected patients | Q36412750 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pre-exposure prophylaxis against HIV | Q7239230 |
| P304 | page(s) | S17-24 | |
| P577 | publication date | 2013-12-01 | |
| P1433 | published in | Antiviral Research | Q4775352 |
| P1476 | title | Rectal pre-exposure prophylaxis (PrEP) | |
| P478 | volume | 100 Suppl | |